On-Demand Webinars

31. Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter 4/9/2026

    Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.

32. From Fermentation To Vaccination 4/8/2026

    Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.

33. Enabling Pharma 4.0 With OCELOT System Control 4/7/2026

    Discover how incremental steps in digitalization and Data Integrity by Design can bridge the gap to Pharma 4.0, enhancing process efficiency and workforce capability without the need for a total overhaul.

34. Scaling MSC Therapies: Overcoming MSC Manufacturing Risks And Barriers 4/1/2026

    Explore strategies for scaling MSC manufacturing while mitigating biological and operational risks. Learn how closed-system platforms and optimized workflows accelerate the path to commercial cell therapy.

35. Digital Design Meets Proven Performance: The Future Of Single-Use Assemblies 3/31/2026

    Single-use assembly design is evolving fast. Learn how scalable platforms, digital automation tools, and global supply networks are converging to support sustainable biopharma manufacturing at scale.

36. A Gentler Workflow: Fc-fusion Protein Purification With Mixed-Mode And Anion Exchange Chromatography 3/26/2026

    Gain insights into comparative performance, workflow flexibility, and practical considerations for implementing a new weak anion exchange hydrophobic resin and a strong anion exchange resin.

37. Applying AI And Rapid Prototyping To Media And Process Development 3/26/2026

    Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.

38. Global Manufacturing Excellence Across Quality, Efficiency, And Cost Of Goods Sold 3/26/2026

    Learn strategies to strengthen global biologics manufacturing through consistent quality, advanced technologies, and efficient tech transfer to improve operations and commercial readiness.

39. Ensure Successful Viral Clearance 3/26/2026

    A decade of viral clearance data comparing established and emerging operations, highlighting LRV performance, key process risks, and practical insights to strengthen downstream safety.

40. Deciphering The Complexity Of Therapeutic Biologics 3/26/2026

    This session breaks down essential analytical approaches that strengthen biologics development, from defining critical quality attributes to supporting comparability and regulatory readiness.